Arterial Occlusive Diseases, Stroke, Thrombectomy
Conditions
Keywords
Stroke, Double Stentriever, Thrombectomy
Brief summary
Several studies have demonstrated that simultaneous treatment with two stentrievers (STs) as rescue treatment is very effective, with high recanalization rates even in this group of patients where other revascularization techniques have failed. There has been no observed increase in hemorrhagic complications. Recently, a prospective study has been published where treatment with two ST has been shown to be effective and safe if used as a first-choice treatment (not as rescue) with a successful recanalization rate (eTICI 2c/3) after the first pass of 69%. These results have been reinforced after the publication of a randomized study that confirms, in vitro, the superiority of using two ST over one.
Detailed description
The use of a double stent retriever has been proposed as a safe and effective technique. The investigators hypothesized that the use of double stentriever primary could lead to higher first pass effect rates and better outcomes compared to single stentriever primary. Our goal is to develop a research project to provide additional information on the potential benefits of the simultaneous double stent approach primarily in stroke patients receiving endovascular treatment. A randomized study to compare the efficacy of double primary stentriever versus single primary stentriever.
Interventions
DEVICEDouble stentriever
Double stentriever technique
DEVICESingle stentriever
Single stentriever technique
Sponsors
Fundación EPIC
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Masking description
Patient & Outcomes adjudicator
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* A new disabling focal neurological deficit compatible with acute cerebral ischemia. * Any age. Informed consent obtained from the patient or representative. * NIHSS score ≥ 6. * Pre-existing functional clinical status less than or equal to 2 according to the mRS clinical scale. * Maximum time of 24 hours from symptom onset to arterial puncture. • TICI 0-1 in the diagnosed TICA (terminal internal carotid artery) , MCA (middle cerebral artery), and BA( basilar artery confirmed by angioCT and angiography). * ASPECTs score on baseline CT greater than or equal to 6. * In cases where it is indicated, prior intravenous fibrinolysis will be administered according to the protocols of each center.
Exclusion criteria
* Those described in the usual protocols for mechanical thrombectomy of each hospital. * Pre-existing functional clinical status greater than 2 according to the mRS clinical scale * Patients with tandem lesions of dissection or arteriosclerotic origin located in the extracranial internal carotid artery. * Initiation of treatment with a different technique than the one described. * Inability to use a proximal balloon guide catheter. * Use of aspiration catheter. * Intracranial atherosclerotic plaque as the cause of occlusion. * Advanced or terminal disease with a life expectancy of less than 6 months. * Patient who is participating in another study that may affect this one. * ASPECTS score less than or equal to 6 on baseline CT. * Evidence of significant hemorrhage or mass effect with midline shift on baseline CT. * Patients with occlusions in multiple vascular territories. * Evidence of intracranial tumor (except for small meningiomas)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| EFFECTIVENESS OBJECTIVE: Complete recanalization on first pass | 90 days | Comparison of the complete recanalization rate in the first pass in the double stent group compared to the single stent group, defined as TICI greater than 2c on the Thrombolysis in Cerebral Infarction scale (eTICI scale). |
| SAFETY OBJECTIVE: Intracerebral hemorrhage. | 24 hours | Rate of patients with symptomatic intracranial hemorrhage (neurological deterioration in National Institutes of Health Stroke Scale \[NIHSS\] \>4) at 24h observed between both groups and, fundamentally, evaluated by CT. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Embolism in new territories. | During the procedure | Rate of embolization to an artery not involved in the initially affected territory. |
| Number of passes with the devices. | During the procedure | Evaluation of the number of passes with the devices during the procedure. |
| Procedure time. | During the procedure | Time from arterial puncture to arterial recanalization, or if not achieved, until the end of the intervention. |
| Arterial Recanalization (eTICI scale) on first pass. | During the procedure | evaluation of the rates of eTICI 3, eTICI 2c/3, eTICI e2b/3 on the Thrombolysis in Cerebral Infarction scale (e TICI scale); range 0-3, with highest score indicating complete recanalization. |
| Arterial recanalization at the end of the procedures. | During the procedure | eTICI 3, eTICI e2c/3, eTICI e2b/3 at the end of the procedure on the Thrombolysis in Cerebral Infarction scale (e TICI scale); range 0-3, with highest score indicating complete recanalization. |
| Intervention success. | During the procedure | Rate of the ability to position both STs in the indicated location. |
| Early neurological improvement. | 24 hours | Rate of patients with a decrease of 10 points or more on the NIHSS scale or complete recovery during the first 24 hours. Improvement of Neurological status at 24 hours, determined by National Institutes of Health Stroke Scale \[NIHSS score\] range 0-42, with higher scores indicating greater stroke severity. |
| National Institutes of Health Stroke Scale (NIHSS) scale at 24 hours, on day 5, or at discharge. | 5 days | Neurological status at 24 hours, at day 5 (+/- 12 hours) or discharge, determined by National Institutes of Health Stroke Scale \[NIHSS score\] range 0-42, with higher scores indicating greater stroke severity. |
| Modified Rankin Scale (mRS) scale at 90 days. | 90 days | Modified Rankin Scale (mRS; range 0 \[no symptoms\] to 6 \[death\] for the evaluation of neurological functional disability score at 90 days |
| Mortality rate. | 90 days | 90-day mortality rate. |
| Intracerebral hemorrhage. | 24 hours | Rate of any type of intracranial hemorrhage on the 24-hour control computed tomography (CT) scan (subarachnoid hemorrhage and hemorrhage according to the classification used in the ECASS study). |
| Complications related to the intervention. | During the procedure | Evaluation of the rate of arterial perforation, angiographic extravasation of contrast, arterial dissection or arterial vasospasm. |
Countries
Germany, Spain
Contacts
Primary ContactPEDRO VEGA VALDES, MD, PhD
Outcome results
None listed